Moreover, decreased ATP23 expression may impair oxidative phosphorylation in T cells, contributing to the formation of an immune-evasive microenvironment, and potentially leading to reduced efficacy of both immunotherapy and conventional chemotherapy.<h4>Conclusions</h4>ATP23 is a potential prognostic marker for COAD patients. The gene discussed is ATP23; the disease is colon adenocarcinoma.